Obstetrics, gynecology and reproductive medicine guidelines

HIV/AIDS

PubMed Free Full Text

Anti-HIV agents: drug resistance

Australia

• Medical Services Advisory Committee
  • Genotypic resistance testing of antiretrovirals in HIV [2004]

Botswana

• PLoS ONE
  • The Emergence of HIV Transmitted Resistance in Botswana: “When Will the WHO Detection Threshold Be Exceeded?” [2007]

India

• Journal of Postgraduate Medicine
  • HIV-1 drug resistance among untreated patients in India: Current status [2006]

South Africa

• AIDS Research and Human Retroviruses
  • Primary Drug Resistance in South Africa: Data from 10 Years of Surveys [2012]

United States of America

• International Antiviral Society-USA
  • 2011 update of the drug resistance mutations in HIV-1 [2011]

• National Guideline Clearinghouse
  • Diagnostic, monitoring, and resistance laboratory tests for HIV. New York State Department of Health [2011]

• New York State Department of Health AIDS Institute
  • Diagnostic, Monitoring, and Resistance Tests for HIV [2011]

WHO

• World Health Organization
  • WHO global strategy for the surveillance and monitoring of HIV drug resistance 2012 [2012]
  • WHO HIV drug resistance report 2012 [2012]
  • HIV drug resistance

Articles in journals

• AIDS
  • Antiretroviral medication adherence and the development of class-specific antiretroviral resistance [2009]

• Clinical and Vaccine Immunology
  • Multiple Effects of the M184V Resistance Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 [2003]

• Clinical Infectious Diseases
  • Clinical Implications of Genotypic Resistance to the Newer Antiretroviral Drugs in HIV-1–Infected Patients with Virological Failure [2010]

• Current Opinion in Virology
  • Drug Resistance in HIV-1 [2011]

• Journal of Antimicrobial Chemotherapy
  • Using HIV resistance tests in clinical practice [2009]
  • Resistance profile of the new nucleoside reverse transcriptase inhibitor apricitabine [2009]
  • New developments in HIV drug resistance [2009]
  • HIV entry inhibitors: mechanisms of action and resistance pathways [2006]
  • The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1 [2003]
  • Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance [2003]

• Journal of Infectious Diseases
  • Minority Variants of Drug-Resistant HIV [2010]

• Journal of Medicinal Chemistry
  • Harnessing Nature’s Insight: Design of Aspartyl Protease Inhibitors from Treatment of Drug-resistant HIV to Alzheimer’s Disease [2009]

• Journal of Postgraduate Medicine
  • Antiretroviral drug resistance testing [2006]

• Retrovirology
  • Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment [2012]

• Viruses
  • Clinical Management of HIV Drug Resistance [2011]

{Related topics}

• Guidelines
  • Anti-HIV agents